Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 36,380 | 28,004 | 29,775 | 23,791 | 19,653 |
| Operating Income | -36,380 | -28,004 | -29,775 | -23,791 | -19,653 |
| Other Income | -138 | 235 | 575 | 885 | 728 |
| Pre-tax Income | -36,518 | -27,769 | -29,200 | -22,906 | -18,925 |
| Net Income Continuous | -37,632 | -27,769 | -29,200 | -22,906 | -18,925 |
| Net Income | $-37,632 | $-27,769 | $-29,200 | $-22,906 | $-18,925 |
| EPS Basic Total Ops | -4.00 | -3.10 | -3.60 | -3.10 | -3.00 |
| EPS Basic Continuous Ops | -3.93 | -3.12 | -3.64 | -3.10 | -2.92 |
| EPS Diluted Total Ops | -4.00 | -3.10 | -3.60 | -3.10 | -3.00 |
| EPS Diluted Continuous Ops | -3.93 | -3.12 | -3.64 | -3.10 | -2.92 |
| EBITDA(a) | $-34,009 | $-28,115 | $-27,776 | $-23,371 | $-19,211 |